Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific and ArthroCare in heart deal:

This article was originally published in Clinica

Executive Summary

Boston Scientific is to develop and market ArthroCare's Coblation technology for use in myocardial revascularisation - the treatment of heart disease in which radiofrequency energy is used to stimulate the formation of new blood vessels. Boston will have exclusive licensing rights to ArthroCare's intellectual property and will pay licensing fees on completion of clinical and regulatory milestones. Financial terms were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT080630

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel